Symbols / OSCR
OSCR Chart
About
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Healthcare Plans | Market Cap | 3.82B |
| Enterprise Value | 169.70M | Income | -443.15M | Sales | 11.70B |
| Book/sh | 3.29 | Cash/sh | 13.42 | Dividend Yield | — |
| Payout | 0.00% | Employees | 2305 | IPO | — |
| P/E | — | Forward P/E | 9.52 | PEG | — |
| P/S | 0.33 | P/B | 3.90 | P/C | — |
| EV/EBITDA | -0.46 | EV/Sales | 0.01 | Quick Ratio | 0.92 |
| Current Ratio | 0.95 | Debt/Eq | 50.86 | LT Debt/Eq | — |
| EPS (ttm) | -1.69 | EPS next Y | 1.35 | EPS Growth | — |
| Revenue Growth | 17.30% | Earnings | 2026-05-11 | ROA | -4.44% |
| ROE | -44.35% | ROIC | — | Gross Margin | 14.38% |
| Oper. Margin | -11.90% | Profit Margin | -3.79% | Shs Outstand | 262.16M |
| Shs Float | 249.45M | Short Float | 10.99% | Short Ratio | 3.08 |
| Short Interest | — | 52W High | 23.80 | 52W Low | 11.20 |
| Beta | 1.90 | Avg Volume | 9.70M | Volume | 2.08M |
| Target Price | $15.40 | Recom | Hold | Prev Close | $12.30 |
| Price | $12.82 | Change | 4.23% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$15.40
Mean price target
2. Current target
$12.82
Latest analyst target
3. DCF / Fair value
$47.93
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$12.82
Low
$10.00
High
$23.00
Mean
$15.40
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-01-09 | up | UBS | Sell → Neutral | $17 |
| 2026-01-05 | up | Barclays | Underweight → Equal-Weight | $18 |
| 2025-12-11 | init | Stephens & Co. | — → Equal-Weight | $17 |
| 2025-11-26 | up | Piper Sandler | Neutral → Overweight | $25 |
| 2025-11-13 | main | Wells Fargo | Underweight → Underweight | $11 |
| 2025-11-10 | main | Barclays | Underweight → Underweight | $13 |
| 2025-11-07 | main | UBS | Sell → Sell | $12 |
| 2025-10-14 | init | Goldman Sachs | — → Neutral | $17 |
| 2025-10-07 | main | Wells Fargo | Underweight → Underweight | $14 |
| 2025-08-14 | main | Piper Sandler | Neutral → Neutral | $13 |
| 2025-07-25 | down | Baird | Outperform → Neutral | $14 |
| 2025-07-23 | main | Barclays | Underweight → Underweight | $11 |
| 2025-07-15 | down | UBS | Neutral → Sell | $11 |
| 2025-07-11 | down | Wells Fargo | Equal-Weight → Underweight | $10 |
| 2025-07-02 | init | Barclays | — → Underweight | $17 |
| 2025-06-09 | main | Piper Sandler | Overweight → Overweight | $18 |
| 2025-03-13 | down | Wells Fargo | Overweight → Equal-Weight | $16 |
| 2024-12-10 | init | Jefferies | — → Underperform | $12 |
| 2024-11-06 | down | B of A Securities | Neutral → Underperform | $14 |
| 2024-10-07 | init | UBS | — → Neutral | $23 |
- Oscar Health Stock Tumbled 22% – Opportunity or Trap? - Trefis Wed, 25 Feb 2026 06
- Oscar Health Tumbles: Can This Insurtech Disruptor Bounce Back? - Forbes Wed, 25 Feb 2026 14
- Longleaf Partners Small-Cap Fund’s Investment in Oscar Health (OSCR) Paid Off - Insider Monkey Wed, 25 Feb 2026 13
- Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a 16.4% Potential Upside Amidst Market Volatility - DirectorsTalk Interviews Mon, 23 Feb 2026 19
- Is 21.7% Fall In Oscar Health (OSCR) Stock A Buying Opportunity? - Trefis Wed, 25 Feb 2026 05
- Oscar Health, Inc. (OSCR) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance Mon, 02 Feb 2026 08
- Oscar Health Inc (OSCR) Stock Price Down 3.35% on Feb 20 - GuruFocus Fri, 20 Feb 2026 17
- Skandinaviska Enskilda Banken AB publ Sells 213,900 Shares of Oscar Health, Inc. $OSCR - MarketBeat Sun, 22 Feb 2026 12
- 2 Top Stocks That Could Double in 2026 - The Motley Fool ue, 23 Dec 2025 08
- Oscar Health Q4: Tricky 2025, Promising 2026 - Long-Term Bull Thesis Attractive (OSCR) - Seeking Alpha Wed, 11 Feb 2026 08
- OSCR Stock Snaps 6-Day Slide Ahead Of Q4 Results: Can The Rebound Survive Post-ACA Subsidy Fears? - Stocktwits Mon, 09 Feb 2026 08
- Why Is Oscar Health (OSCR) Stock Soaring Today - Yahoo Finance Mon, 05 Jan 2026 08
- Oscar Health Stock Is a Screaming Buy Right Now - The Motley Fool Wed, 11 Feb 2026 08
- Is 25.4% Fall In Oscar Health (OSCR) Stock A Buying Opportunity? - Trefis Wed, 04 Feb 2026 08
- Oscar Health (OSCR) Stock Trades Up, Here Is Why - Yahoo Finance ue, 10 Feb 2026 08
Insider Transactions
| Date | Shares | Url | Text | Insider | Position | Transaction | Start Date | Ownership | Value |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 23038 | — | — | SCHLOSSER MARIO T | Chief Technology Officer | — | 2026-01-08 00:00:00 | D | nan |
| 1 | 23038 | — | Sale at price 17.65 per share. | SCHLOSSER MARIO T | Chief Technology Officer | — | 2026-01-08 00:00:00 | D | 406621.0 |
| 2 | 76962 | — | — | SCHLOSSER MARIO T | Chief Technology Officer | — | 2026-01-06 00:00:00 | D | nan |
| 3 | 76962 | — | Sale at price 17.01 per share. | SCHLOSSER MARIO T | Chief Technology Officer | — | 2026-01-06 00:00:00 | D | 1309124.0 |
| 4 | 146693 | — | — | SCHLOSSER MARIO T | Chief Technology Officer | — | 2026-01-05 00:00:00 | D | nan |
| 5 | 234861 | — | Sale at price 15.02 - 15.64 per share. | SCHLOSSER MARIO T | Chief Technology Officer | — | 2026-01-05 00:00:00 | D | 3587708.0 |
| 6 | 38835 | — | Sale at price 15.00 per share. | SCHLOSSER MARIO T | Chief Technology Officer | — | 2025-12-24 00:00:00 | D | 582525.0 |
| 7 | 25135 | — | Sale at price 16.59 per share. | BLACKLEY RICHARD SCOTT | Chief Financial Officer | — | 2025-12-02 00:00:00 | D | 416990.0 |
| 8 | 1852 | — | Sale at price 16.59 per share. | MCANANEY ADAM | Officer | — | 2025-12-02 00:00:00 | D | 30725.0 |
| 9 | 23965 | — | Sale at price 16.59 per share. | SCHLOSSER MARIO T | Chief Technology Officer | — | 2025-12-02 00:00:00 | D | 397579.0 |
Financials
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.21 | 0.22 | 0.21 | 0.00 |
| TotalUnusualItems | 0.00 | 0.00 | -20.18M | |
| TotalUnusualItemsExcludingGoodwill | 0.00 | 0.00 | -20.18M | |
| NetIncomeFromContinuingOperationNetMinorityInterest | -443.15M | 25.43M | -270.73M | -606.27M |
| ReconciledDepreciation | 28.89M | 32.15M | 30.69M | 15.28M |
| EBIT | -419.70M | 57.16M | -242.70M | -587.45M |
| NetInterestIncome | -17.60M | -23.73M | -24.60M | -22.62M |
| InterestExpense | 17.60M | 23.73M | 24.60M | 22.62M |
| InterestIncome | 31.31M | 10.25M | ||
| NormalizedIncome | -443.15M | 25.43M | -270.73M | -606.27M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -443.15M | 25.43M | -270.73M | -606.27M |
| TotalExpenses | 12.14B | 9.14B | 6.13B | 4.74B |
| DilutedAverageShares | 262.39M | 265.85M | 221.66M | 212.47M |
| BasicAverageShares | 262.39M | 265.85M | 221.66M | 212.47M |
| DilutedEPS | -1.69 | 0.10 | -1.22 | -2.85 |
| BasicEPS | -1.69 | 0.10 | -1.22 | -2.85 |
| DilutedNIAvailtoComStockholders | -443.15M | 25.43M | -270.73M | -606.27M |
| NetIncomeCommonStockholders | -443.15M | 25.43M | -270.73M | -606.27M |
| NetIncome | -443.15M | 25.43M | -270.73M | -606.27M |
| MinorityInterests | -248.00K | -689.00K | -134.00K | 3.28M |
| NetIncomeIncludingNoncontrollingInterests | -442.90M | 26.12M | -270.59M | -609.55M |
| NetIncomeContinuousOperations | -442.90M | 26.12M | -270.59M | -609.55M |
| TaxProvision | 5.61M | 7.30M | 3.29M | -523.00K |
| PretaxIncome | -437.30M | 33.43M | -267.30M | -610.08M |
| OtherIncomeExpense | 3.88M | 5.30M | ||
| SpecialIncomeCharges | 0.00 | 0.00 | -20.18M | |
| OtherSpecialCharges | 20.18M | |||
| NetNonOperatingInterestIncomeExpense | -17.60M | -23.73M | -24.60M | -22.62M |
| InterestExpenseNonOperating | 17.60M | 23.73M | 24.60M | 22.62M |
| OtherOperatingExpenses | 23.34M | 105.00K | 7.08M | -2.42M |
| DepreciationAndAmortizationInIncomeStatement | 28.89M | 32.15M | 30.69M | 15.28M |
| SellingGeneralAndAdministration | 2.05B | 1.76B | 1.42B | 1.42B |
| GeneralAndAdministrativeExpense | 2.05B | 1.76B | 1.42B | 1.42B |
| OtherGandA | 2.05B | 1.76B | 1.42B | 1.42B |
| TotalRevenue | 11.70B | 9.18B | 5.86B | 4.13B |
| OperatingRevenue | 11.70B | 9.18B | 5.86B | 4.13B |
| LossAdjustmentExpense | 10.02B | 7.33B | 4.64B | 3.28B |
| NetPolicyholderBenefitsAndClaims | 10.02B | 7.33B | 4.64B | 3.28B |
| PolicyholderBenefitsGross | 10.16B | 7.49B | 4.69B | 4.57B |
| PolicyholderBenefitsCeded | 144.15M | 159.13M | 44.74M | 1.29B |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TreasurySharesNumber | 315.00K | 315.00K | 314.60K | 314.60K |
| OrdinarySharesNumber | 297.69M | 250.49M | 229.39M | 216.29M |
| ShareIssued | 298.00M | 250.80M | 229.70M | 216.61M |
| TotalDebt | 430.10M | 299.56M | 298.78M | 298.00M |
| TangibleBookValue | 977.65M | 1.01B | 803.97M | 890.38M |
| InvestedCapital | 1.41B | 1.31B | 1.10B | 1.19B |
| NetTangibleAssets | 977.65M | 1.01B | 803.97M | 890.38M |
| CommonStockEquity | 977.65M | 1.01B | 803.97M | 890.38M |
| TotalCapitalization | 1.41B | 1.31B | 1.10B | 1.19B |
| TotalEquityGrossMinorityInterest | 980.74M | 1.02B | 806.12M | 892.40M |
| MinorityInterest | 3.09M | 2.84M | 2.15M | 2.02M |
| StockholdersEquity | 977.65M | 1.01B | 803.97M | 890.38M |
| GainsLossesNotAffectingRetainedEarnings | 18.03M | -1.83M | 1.31M | -9.71M |
| OtherEquityAdjustments | 18.03M | -1.83M | 1.31M | -9.71M |
| TreasuryStock | 2.92M | 2.92M | 2.92M | 2.92M |
| RetainedEarnings | -3.29B | -2.85B | -2.88B | -2.61B |
| AdditionalPaidInCapital | 4.26B | 3.87B | 3.68B | 3.51B |
| CapitalStock | 3.00K | 2.00K | 2.00K | 2.00K |
| CommonStock | 3.00K | 2.00K | 2.00K | 2.00K |
| PreferredStock | 0.00 | 0.00 | ||
| TotalLiabilitiesNetMinorityInterest | 5.34B | 3.82B | 2.80B | 3.63B |
| PreferredSecuritiesOutsideStockEquity | 0.00 | |||
| DerivativeProductLiabilities | 0.00 | |||
| LongTermDebtAndCapitalLeaseObligation | 430.10M | 299.56M | 298.78M | 298.00M |
| LongTermDebt | 430.10M | 299.56M | 298.78M | 298.00M |
| PayablesAndAccruedExpenses | 4.05B | 2.96B | 2.08B | 2.88B |
| Payables | 4.05B | 2.96B | 2.08B | 2.88B |
| OtherPayable | 2.59B | 1.56B | 1.06B | 1.52B |
| AccountsPayable | 1.46B | 1.40B | 1.03B | 1.37B |
| TotalAssets | 6.33B | 4.84B | 3.60B | 4.53B |
| InvestmentsAndAdvances | 1.22B | 624.46M | 689.83M | 1.40B |
| NetPPE | 88.35M | 66.79M | 61.93M | 59.89M |
| Receivables | 598.46M | 672.21M | 494.39M | 1.16B |
| OtherReceivables | 56.07M | 64.78M | 51.92M | 49.86M |
| AccountsReceivable | 542.39M | 607.43M | 442.46M | 1.11B |
| CashCashEquivalentsAndShortTermInvestments | 3.99B | 2.15B | 2.56B | 2.96B |
| OtherShortTermInvestments | 1.22B | 624.46M | 689.83M | 1.40B |
| CashAndCashEquivalents | 2.77B | 1.53B | 1.87B | 1.56B |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| FreeCashFlow | 1.06B | 950.30M | -297.74M | 351.34M |
| RepurchaseOfCapitalStock | 0.00 | |||
| RepaymentOfDebt | 0.00 | 0.00 | -153.17M | |
| IssuanceOfDebt | 410.00M | 0.00 | 0.00 | 305.00M |
| IssuanceOfCapitalStock | 0.00 | 0.00 | 1.35B | |
| CapitalExpenditure | -36.37M | -27.90M | -25.58M | -29.01M |
| InterestPaidSupplementalData | 12.78M | 33.69M | 23.16M | 10.08M |
| IncomeTaxPaidSupplementalData | 17.52M | 674.00K | 2.41M | 1.89M |
| EndCashPosition | 2.80B | 1.55B | 1.89B | 1.58B |
| BeginningCashPosition | 1.55B | 1.89B | 1.58B | 1.13B |
| ChangesInCash | 1.25B | -340.85M | 311.47M | 454.94M |
| FinancingCashFlow | 399.21M | 68.39M | 6.45M | 301.11M |
| CashFlowFromContinuingFinancingActivities | 399.21M | 68.39M | 6.45M | 301.11M |
| NetOtherFinancingCharges | -65.82M | 2.49M | -5.19M | -15.21M |
| ProceedsFromStockOptionExercised | 55.03M | 68.39M | 3.96M | 1.30M |
| NetPreferredStockIssuance | 0.00 | 0.00 | ||
| PreferredStockIssuance | 0.00 | 0.00 | ||
| NetCommonStockIssuance | 0.00 | 0.00 | 1.35B | |
| CommonStockPayments | 0.00 | |||
| CommonStockIssuance | 0.00 | 0.00 | 1.35B | |
| NetIssuancePaymentsOfDebt | 410.00M | 0.00 | 0.00 | 305.00M |
| NetLongTermDebtIssuance | 410.00M | 305.00M | -153.17M | |
| LongTermDebtPayments | 0.00 | 0.00 | -153.17M | |
| LongTermDebtIssuance | 410.00M | 0.00 | 0.00 | 305.00M |
| InvestingCashFlow | -241.06M | -1.39B | 577.19M | -226.52M |
| CashFlowFromContinuingInvestingActivities | -241.06M | -1.39B | 577.19M | -226.52M |
| NetOtherInvestingChanges | 4.28M | 3.93M | -2.28M | 1.12M |
| NetInvestmentPurchaseAndSale | -208.96M | -1.36B | 605.04M | -198.62M |
| SaleOfInvestment | 804.96M | 770.04M | 1.44B | 994.08M |
| PurchaseOfInvestment | -1.01B | -2.13B | -836.98M | -1.19B |
| NetPPEPurchaseAndSale | -36.37M | -27.90M | -25.58M | -29.01M |
| PurchaseOfPPE | -36.37M | -27.90M | -25.58M | -29.01M |
| OperatingCashFlow | 1.09B | 978.19M | -272.16M | 380.35M |
| CashFlowFromContinuingOperatingActivities | 1.09B | 978.19M | -272.16M | 380.35M |
| ChangeInWorkingCapital | 1.46B | 838.86M | -192.09M | 855.00M |
| ChangeInOtherCurrentAssets | -27.12M | -11.55M | 11.31M | -243.00K |
| ChangeInPayablesAndAccruedExpense | 1.20B | 634.49M | -856.36M | 1.00B |
| ChangeInPayable | 1.20B | 634.49M | -856.36M | 1.00B |
| ChangeInAccountPayable | 167.72M | 133.09M | -395.81M | 280.23M |
| ChangeInReceivables | 98.57M | -177.52M | 636.23M | -551.15M |
| ChangesInAccountReceivables | 89.86M | -164.67M | 638.29M | -541.95M |
| OtherNonCashItems | -10.74M | -300.00K | 28.61M | 2.99M |
| StockBasedCompensation | 87.65M | 109.82M | 159.68M | 112.33M |
| AmortizationOfSecurities | -29.79M | -26.88M | -29.37M | 2.48M |
| DeferredTax | 2.45M | -2.34M | 58.00K | -165.00K |
| DeferredIncomeTax | 2.45M | -2.34M | 58.00K | -165.00K |
| DepreciationAndAmortization | 28.89M | 32.15M | 30.69M | 15.28M |
| OperatingGainsLosses | -1.34M | -23.00K | 70.00K | 1.27M |
| GainLossOnInvestmentSecurities | -1.34M | -23.00K | 70.00K | 1.27M |
| NetIncomeFromContinuingOperations | -442.90M | 26.12M | -270.59M | -609.55M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for OSCR
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|